查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867225

Fentanyl市场按产品类型、给药途径、用途和分销管道划分－2025-2032年全球预测

Fentanyl Market by Product Type, Route of Administration, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，Fentanyl市场规模将成长至 34.4 亿美元，复合年增长率为 4.78%。

关键市场统计数据
基准年 2024 23.6亿美元
预计年份：2025年 24.7亿美元
预测年份 2032 34.4亿美元
复合年增长率 (%) 4.78%

对Fentanyl在现代医学中的双重作用以及影响其临床获取和管理的公共卫生需求进行清晰、全面的概述。

Fentanyl的使用现况处于临床需求与公共卫生紧迫交织的复杂境地。合成鸦片类药物在麻醉、急性疼痛管理和安宁疗护中发挥着至关重要的作用，同时也是减少鸦片类药物相关危害的更广泛努力的核心。因此，从医院处方集和药物研发团队到监管机构和减害组织，所有利益相关相关人员都面临着相互衝突的迫切需求：既要维持适当的临床用药途径，又要限制非法分销和滥用，还要适应不断变化的供应链和监管压力。

剂量创新、监管收紧和供应链韧性正在共同作用，重新定义临床实践和商业策略。

由于製剂创新、监管加强和供应链重组，Fentanyl市场正经历变革性变化。新型给药技术，例如更精准的经皮基质和专为紧急给药设计的鼻腔给药系统，在拓展临床选择的同时，也提出了新的管控和监测要求。同时，法规结构日趋分散，监管机构正加强对处方行为、通路管控和上市后监测机制的审查。

2025年美国关税环境及由此产生的策略采购因应措施将重塑整个价值链的供应连续性和监管合规性。

2025年美国关税的实施，为从事Fentanyl合法生产和分销的公司带来了新的营运复杂性。关税相关的成本压力促使製造商重新评估其活性药物​​原料药和关键生产材料的采购区域和供应商关係。为此，采购部门正在寻求供应商多元化，并探索近岸外包方案，以降低关税波动带来的风险，同时确保持续向关键医院和药局供应药品。

一个复杂的细分框架，将产品配方、给药途径、临床应用和分销与策略重点连结起来。

细分市场分析揭示了不同产品类型、给药途径、临床应用和分销管道的市场需求驱动因素，这些因素对临床实践、法律规范和商业规划均有独特的影响。根据产品类型，市场参与企业必须满足注射剂、锭剂/片剂、滴鼻剂和贴片各自独特的临床和生产要求。注射剂的无菌生产和低温运输要求与锭剂和片剂的製剂稳定性和防滥用设计挑战形成鲜明对比。同时，滴鼻剂和贴片各自具有独特的给药动力学和使用者介面因素，这些因素会影响患者疗效和潜在的误用风险。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 分析街头毒品混合物中Fentanyl含量不断上升的趋势及其对市场的影响
  • 北美针对Fentanyl生产的合成鸦片类药物前驱物的新法规结构
  • 执法部门利用快速路边检测技术检测Fentanyl的进展
  • 都市区消费者对处方阿片的需求转向非法製造的Fentanyl
  • 新冠感染疾病对Fentanyl贩运路线与供应链韧性的影响
  • 暗网市场的发展使得Fentanyl的匿名销售成为可能，并对其市场准入性产生了影响。
  • 旨在降低Fentanyl成瘾率的疫苗和免疫疗法研究创新
  • 诸如监管式戒毒机构等减少危害策略在降低Fentanyl过量致死率方面的作用
  • 中国对芬太尼前体出口的限制对全球Fentanyl合成和分销网络的影响
  • 整合人工智慧和预测分析技术，预测Fentanyl滥用热点地区和介入需求

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的Fentanyl市场

  • 注射
  • 片剂和锭剂
  • 滴鼻剂
  • 修补

第九章Fentanyl市场依给药途径划分

  • 口服
  • 肠外给药
  • 经皮

第十章Fentanyl市场按应用划分

  • 医疗用途
    • 麻醉
    • 疼痛管理
    • 安宁疗护
  • 研究与开发

第十一章Fentanyl市场按分销管道划分

  • 医院药房
  • 零售药房

第十二章Fentanyl市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章Fentanyl市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国Fentanyl市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Alvogen
    • Apotex Inc.
    • Biesterfeld SE
    • Daiichi Sankyo Company, Limited
    • Fresenius SE & Co. KGaA
    • Hikma Pharmaceuticals PLC
    • Humanwell Healthcare（Group）Co., Ltd.
    • Kyowa Hakko Kirin Co. Ltd.
    • Mallinckrodt plc
    • Nutriband Inc.
    • Pfizer Inc.
    • Piramal Pharma Limited
    • QuVa Pharma, Inc
    • SCA Pharma
    • Spectrum Chemical Mfg. Corp.
    • Terumo Corporation
    • Teva Pharmaceutical Industries Ltd.
    • Tofigh Daru Research & Engineering Company
    • Verve HumanCare Laboratories
    • Viatris Inc.
Product Code: MRR-CB04E056533E

The Fentanyl Market is projected to grow by USD 3.44 billion at a CAGR of 4.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.36 billion
Estimated Year [2025] USD 2.47 billion
Forecast Year [2032] USD 3.44 billion
CAGR (%) 4.78%

A clear contextual overview of fentanyl's dual role in modern medicine and the public health imperative shaping clinical access and control

The fentanyl landscape occupies a complex intersection of clinical necessity and public health urgency. Synthetic opioids serve indispensable roles in anesthesia, acute pain management, and palliative care, while simultaneously being central to broader efforts to reduce opioid-related harm. As a result, stakeholders from hospital formularies and pharma development teams to regulators and harm-reduction organizations face competing imperatives: preserve appropriate clinical access, limit diversion and misuse, and adapt to shifting supply chain and regulatory pressures.

Over recent years, technological advances in formulation and delivery, combined with intensified law enforcement and public health interventions, have reshaped how fentanyl is manufactured, distributed, and used. At the same time, legitimate clinical demand continues to drive innovation in transdermal systems, nasal spray options for emergency use, and rapidly acting injectables for controlled settings. Consequently, the sector demands nuanced strategies that reconcile therapeutic benefit with tighter controls and heightened public scrutiny.

This introduction establishes the context for a comprehensive exploration of market dynamics, regulatory influences, and operational considerations. It frames the subsequent analysis so that clinical leaders, supply chain managers, and policy teams can assess risk, prioritize investments, and design interventions that maintain patient care standards while mitigating externalities such as diversion and illicit manufacture.

How innovation in delivery, regulatory tightening, and supply chain resilience are jointly redefining clinical practice and commercial strategy

The fentanyl landscape is undergoing transformative shifts driven by innovation in formulations, regulatory tightening, and a reconfiguration of supply chains. Novel delivery technologies, including more precise transdermal matrices and intranasal systems designed for emergency administration, are widening clinical options while also raising new stewardship and monitoring requirements. Concurrently, regulatory frameworks are becoming more granular, with authorities increasing scrutiny of prescribing practices, distribution channel controls, and post-market surveillance mechanisms.

Supply chain resilience has emerged as a critical axis of change. Manufacturers and distributors are reevaluating sourcing strategies for active pharmaceutical ingredients, implementing enhanced traceability protocols, and investing in manufacturing security to reduce vulnerability to diversion. At the same time, research and development priorities are shifting toward formulations that balance rapid onset with abuse-deterrent features, creating pressure for cross-functional collaboration between formulation scientists, clinical teams, and compliance officers.

Taken together, these shifts require organizations to adapt their operating models, aligning clinical development, procurement, and regulatory affairs under a unified risk-management framework. The evolving landscape also amplifies the role of stakeholder engagement, as collaboration with payers, providers, and public health agencies becomes essential to deploying therapeutic options responsibly and effectively.

The 2025 U.S. tariff environment and resultant strategic procurement responses reshaping supply continuity and regulatory compliance across the value chain

United States tariffs instituted in 2025 introduced an additional layer of operational complexity for companies involved in legitimate fentanyl production and distribution. Tariff-related cost pressures have prompted manufacturers to reassess sourcing geographies and supplier relationships for active pharmaceutical ingredients and key manufacturing inputs. In response, procurement teams have initiated supplier diversification efforts and explored nearshoring options to mitigate exposure to tariff volatility while preserving continuity for critical hospital and pharmacy supplies.

These trade policy changes have also accelerated conversations around supply chain transparency and vertical integration. Organizations are prioritizing investments in serialization, enhanced supplier audits, and contractual mechanisms that allocate tariff risk across the value chain. At the same time, regulatory compliance functions are tracking how import/export documentation and controlled-substance regulations interplay with tariff classifications to avoid inadvertent disruptions at customs clearance points.

Clinicians and hospital administrators are watching procurement implications carefully, as changes in supplier relationships can affect lead times and formulation availability. Accordingly, cross-functional teams are required to model scenario responses that preserve therapeutic access, especially for anesthesia and palliative care settings where continuity is paramount. The tariff environment has therefore reinforced the need for adaptable procurement strategies, robust supply monitoring, and proactive engagement with trade counsel to navigate regulatory and fiscal requirements effectively.

A nuanced segmentation framework linking product formulation, administration pathways, clinical application, and distribution realities to strategic priorities

Segmentation analysis reveals differentiated demand drivers across product types, administration routes, clinical applications, and distribution channels, each of which carries distinct implications for clinical practice, regulatory oversight, and commercial planning. Based on Product Type, market participants must navigate the unique clinical and manufacturing requirements of Injectables, Lozenges & Tablets, Nasal Sprays, and Patches; the sterile manufacturing and cold-chain considerations for injectables contrast sharply with the formulation stability and abuse-deterrent design challenges for lozenges and tablets, while nasal sprays and patches each introduce unique delivery kinetics and user-interface factors that affect both patient outcomes and misuse potential.

Based on Route of Administration, the clinical pathways differ significantly between Oral, Parenteral, and Transdermal approaches; parenteral administration remains essential for operating-room anesthesia and acute inpatient pain control, oral routes are predominant for controlled outpatient dosing and short-term pain management, and transdermal systems provide sustained release options particularly relevant to palliative care and chronic pain under close supervision. Based on Application, stakeholders must balance requirements for Medical Use and Research & Development, where Medical Use further subdivides into Anesthesia, Pain Management, and Palliative Care; each application imposes distinct evidence needs, prescribing patterns, and stewardship priorities, with anesthesia demanding predictable rapid onset, pain management requiring titratable dosing strategies, and palliative care emphasizing prolonged, comfortable symptom relief.

Based on Distribution Channel, hospitals pharmacies and retail pharmacies present contrasting operational realities; hospital pharmacies handle complex inpatient regimens and controlled administration environments while retail pharmacies must manage dispensing controls, patient counseling, and outpatient adherence challenges. Integrating these segmentation lenses enables clinical development teams and supply chain leaders to target product design, risk mitigation, and distribution policies with precision, thereby aligning regulatory engagement, commercial approaches, and stewardship programs to each segment's specific requirements.

How distinct regional regulatory regimes, supply infrastructures, and clinical priorities across the Americas, EMEA, and Asia-Pacific determine strategic execution and access pathways

Regional dynamics play a decisive role in clinical practice patterns, regulatory frameworks, and supply chain architectures, with distinct operational and policy environments across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, healthcare systems exhibit a strong emphasis on both acute care access and harm-reduction policies, leading to concentrated demand for rapid-onset injectables and emergency nasal formulations alongside intensified monitoring of outpatient dispensing. Regulatory agencies in the region are increasingly focused on balancing clinical need with tighter prescribing controls, and stakeholders must engage proactively with public health initiatives to maintain appropriate therapeutic availability.

In Europe, Middle East & Africa, regulatory heterogeneity and varying levels of infrastructure maturity shape adoption pathways for advanced delivery systems. Some European markets prioritize stringent pharmacovigilance and tighter preauthorization procedures, while healthcare delivery models across the Middle East and Africa may prioritize supply chain robustness and capacity-building to ensure consistent access in hospital settings. These regional distinctions affect how manufacturers approach clinical evidence generation and market access strategies.

The Asia-Pacific region presents a mix of rapidly evolving regulatory frameworks, manufacturing capability expansion, and significant patient populations with unmet pain management needs. Investments in local production capacity and distribution networks are expanding, with incremental adoption of transdermal and nasal emergency formulations. Across regions, successful strategies require tailored regulatory engagement, adaptive supply planning, and culturally informed clinical education to ensure safe and effective therapeutic use while responding to local public health priorities.

Competitive strategies and collaborative capabilities that prioritize secure manufacturing, differentiated delivery technologies, and regulatory-aligned commercialization

Industry participants range from specialized pharmaceutical developers to large integrated manufacturers and contract development and manufacturing organizations, each bringing different capabilities in formulation science, controlled-substance compliance, and commercialization. Leading clinical developers are investing in abuse-deterrent technologies and user-centric delivery designs to meet clinician expectations for predictable efficacy and improved safety profiles. Contract manufacturers are expanding secure production capacities and bolstering quality systems to support sterile injectables and complex transdermal matrices, while distributors are enhancing traceability and chain-of-custody practices to address regulatory and payer scrutiny.

Across the competitive landscape, collaboration between developers, manufacturers, and healthcare institutions is increasingly important. Strategic partnerships enable accelerated clinical validation and distribution scale-up, while alliances with academic centers and clinical networks support evidence generation in specialized applications such as anesthesia protocols and palliative care regimens. Concurrently, firms with deep regulatory expertise are securing advantages by shaping labeling, risk mitigation strategies, and post-market surveillance frameworks that meet evolving expectations from authorities.

Taken together, company strategies are coalescing around secure manufacturing, differentiated delivery technologies, and integrated compliance solutions. Organizations that can combine scientific rigor with operational security and stakeholder engagement will be best positioned to address both clinical demand and regulatory obligations.

High-impact recommendations for clinical developers and supply chain leaders to secure patient access, manage regulatory risk, and build resilient operations

Industry leaders must adopt a multi-pronged approach that integrates clinical evidence generation, supply chain resilience, and proactive regulatory engagement to navigate the complex fentanyl landscape. First, prioritize formulation investments that enhance patient safety and support stewardship objectives, including abuse-deterrent properties and delivery designs that minimize diversion risk while maintaining clinical efficacy. Align clinical development programs with real-world evidence initiatives to demonstrate therapeutic value across anesthesia, pain management, and palliative care contexts, thereby facilitating informed prescribing and institutional adoption.

Second, strengthen supply chain transparency and supplier diversification to reduce exposure to trade policy shifts and other disruptions. Implement serialization, enhanced traceability, and contractual risk-sharing mechanisms, while exploring nearshoring opportunities for critical intermediates and finished goods. Third, engage early and consistently with regulators and payers to co-develop pragmatic access pathways and post-market monitoring strategies that address safety concerns without undermining legitimate clinical use. Finally, invest in stakeholder education and cross-sector partnerships with hospitals, pharmacies, and public health organizations to build trust and operational readiness for new formulations and stewardship programs.

By executing these actions in combination, organizations can protect patient access, reduce systemic risk, and create defensible competitive positions based on safety, reliability, and clinical alignment.

A robust, triangulated research approach combining primary clinician and supply chain interviews with comprehensive secondary evidence and expert validation

The research methodology underpinning this analysis integrates a triangulated approach combining primary stakeholder interviews, targeted secondary source synthesis, and cross-functional validation to ensure both depth and reliability. Primary engagement included consultations with clinicians across anesthesia, pain management, and palliative care, procurement and logistics leaders in hospital systems, regulatory affairs specialists, and manufacturing executives with controlled-substance experience. These stakeholder inputs informed the identification of operational pain points, adoption barriers, and formulation priorities.

Secondary analysis leveraged peer-reviewed clinical literature, regulatory guidance documents, and public health surveillance reports to contextualize clinical needs and policy trajectories. In addition, supply chain documentation and trade policy records were examined to map sourcing risks and tariff implications. Data synthesis employed thematic coding to identify recurrent trends and to align strategic implications with observable operational shifts. Finally, findings were validated through iterative reviews with subject matter experts to ensure accuracy and practical relevance for decision-makers across development, procurement, and regulatory functions.

Synthesis of clinical, operational, and regulatory priorities highlighting the imperative for integrated strategies that protect patient care and supply continuity

In conclusion, the fentanyl landscape presents an intricate balance between indispensable clinical benefits and escalating operational and regulatory complexity. Innovations in delivery and formulation offer meaningful opportunities to improve patient outcomes, but they must be accompanied by strengthened manufacturing security, proactive regulatory engagement, and targeted stewardship efforts. Trade policy developments and regional regulatory variation further complicate supply continuity and access pathways, underscoring the importance of adaptable procurement strategies and cross-functional coordination.

Organizations that align clinical development with real-world evidence generation, invest in secure and traceable supply chains, and engage constructively with regulators and health system stakeholders will be best positioned to navigate these challenges. Ultimately, success requires an integrated response that protects patient care, mitigates risks of diversion, and supports sustainable operational models in a dynamic global environment. This report provides the actionable intelligence needed to inform those strategic decisions and to drive responsible, patient-centered clinical access.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Analysis of the rising prevalence of carfentanil in street drug mixtures and its market implications
  • 5.2. Emerging regulatory frameworks targeting synthetic opioid precursors in North American fentanyl production
  • 5.3. Advancements in rapid roadside testing technologies for fentanyl detection by law enforcement agencies
  • 5.4. Shifts in consumer demand from prescription opioids to illicitly manufactured fentanyl in urban communities
  • 5.5. Impact of COVID-19 pandemic disruptions on fentanyl trafficking routes and supply chain resilience
  • 5.6. Growth of darknet marketplaces facilitating anonymous fentanyl sales and its effect on market accessibility
  • 5.7. Innovations in vaccine and immunotherapy research aimed at reducing fentanyl addiction rates
  • 5.8. Role of harm reduction strategies like supervised consumption sites in curbing fentanyl overdose fatalities
  • 5.9. Influence of Chinese precursor export controls on global fentanyl synthesis and distribution networks
  • 5.10. Integration of AI and predictive analytics for forecasting fentanyl abuse hotspots and intervention needs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fentanyl Market, by Product Type

  • 8.1. Injectables
  • 8.2. Lozenges & Tablets
  • 8.3. Nasal Sprays
  • 8.4. Patches

9. Fentanyl Market, by Route of Administration

  • 9.1. Oral
  • 9.2. Parenteral
  • 9.3. Transdermal

10. Fentanyl Market, by Application

  • 10.1. Medical Use
    • 10.1.1. Anesthesia
    • 10.1.2. Pain Management
    • 10.1.3. Palliative Care
  • 10.2. Research & Development

11. Fentanyl Market, by Distribution Channel

  • 11.1. Hospitals Pharmacies
  • 11.2. Retail Pharmacies

12. Fentanyl Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fentanyl Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fentanyl Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Alvogen
    • 15.3.2. Apotex Inc.
    • 15.3.3. Biesterfeld SE
    • 15.3.4. Daiichi Sankyo Company, Limited
    • 15.3.5. Fresenius SE & Co. KGaA
    • 15.3.6. Hikma Pharmaceuticals PLC
    • 15.3.7. Humanwell Healthcare (Group) Co., Ltd.
    • 15.3.8. Kyowa Hakko Kirin Co. Ltd.
    • 15.3.9. Mallinckrodt plc
    • 15.3.10. Nutriband Inc.
    • 15.3.11. Pfizer Inc.
    • 15.3.12. Piramal Pharma Limited
    • 15.3.13. QuVa Pharma, Inc
    • 15.3.14. SCA Pharma
    • 15.3.15. Spectrum Chemical Mfg. Corp.
    • 15.3.16. Terumo Corporation
    • 15.3.17. Teva Pharmaceutical Industries Ltd.
    • 15.3.18. Tofigh Daru Research & Engineering Company
    • 15.3.19. Verve HumanCare Laboratories
    • 15.3.20. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FENTANYL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS FENTANYL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL FENTANYL MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. FENTANYL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. FENTANYL MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FENTANYL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FENTANYL MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FENTANYL MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FENTANYL MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FENTANYL MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FENTANYL MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FENTANYL MARKET SIZE, BY INJECTABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FENTANYL MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FENTANYL MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FENTANYL MARKET SIZE, BY LOZENGES & TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FENTANYL MARKET SIZE, BY LOZENGES & TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FENTANYL MARKET SIZE, BY LOZENGES & TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FENTANYL MARKET SIZE, BY LOZENGES & TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FENTANYL MARKET SIZE, BY LOZENGES & TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FENTANYL MARKET SIZE, BY LOZENGES & TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FENTANYL MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FENTANYL MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FENTANYL MARKET SIZE, BY NASAL SPRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FENTANYL MARKET SIZE, BY NASAL SPRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FENTANYL MARKET SIZE, BY NASAL SPRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FENTANYL MARKET SIZE, BY NASAL SPRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FENTANYL MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FENTANYL MARKET SIZE, BY PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FENTANYL MARKET SIZE, BY PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FENTANYL MARKET SIZE, BY PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FENTANYL MARKET SIZE, BY PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FENTANYL MARKET SIZE, BY PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FENTANYL MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FENTANYL MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FENTANYL MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FENTANYL MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FENTANYL MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FENTANYL MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FENTANYL MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FENTANYL MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FENTANYL MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FENTANYL MARKET SIZE, BY PARENTERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FENTANYL MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FENTANYL MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FENTANYL MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FENTANYL MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FENTANYL MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FENTANYL MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FENTANYL MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FENTANYL MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FENTANYL MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FENTANYL MARKET SIZE, BY ANESTHESIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FENTANYL MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FENTANYL MARKET SIZE, BY ANESTHESIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FENTANYL MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FENTANYL MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FENTANYL MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FENTANYL MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FENTANYL MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FENTANYL MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FENTANYL MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FENTANYL MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FENTANYL MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FENTANYL MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FENTANYL MARKET SIZE, BY PALLIATIVE CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FENTANYL MARKET SIZE, BY PALLIATIVE CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FENTANYL MARKET SIZE, BY PALLIATIVE CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FENTANYL MARKET SIZE, BY PALLIATIVE CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FENTANYL MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FENTANYL MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FENTANYL MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FENTANYL MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FENTANYL MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FENTANYL MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FENTANYL MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FENTANYL MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FENTANYL MARKET SIZE, BY HOSPITALS PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FENTANYL MARKET SIZE, BY HOSPITALS PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FENTANYL MARKET SIZE, BY HOSPITALS PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FENTANYL MARKET SIZE, BY HOSPITALS PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FENTANYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FENTANYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FENTANYL MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FENTANYL MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FENTANYL MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FENTANYL MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS FENTANYL MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS FENTANYL MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. MIDDLE EAST FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. MIDDLE EAST FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 166. MIDDLE EAST FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. AFRICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. AFRICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. AFRICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 178. AFRICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL FENTANYL MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL FENTANYL MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. ASEAN FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. ASEAN FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. ASEAN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. ASEAN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. ASEAN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 204. ASEAN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. GCC FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GCC FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GCC FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. GCC FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. GCC FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 216. GCC FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 217. GCC FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. GCC FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. GCC FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 220. GCC FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 221. GCC FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. GCC FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPEAN UNION FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPEAN UNION FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPEAN UNION FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. BRICS FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. BRICS FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. BRICS FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. BRICS FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. BRICS FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 240. BRICS FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. G7 FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. G7 FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. G7 FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. G7 FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. G7 FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 252. G7 FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 253. G7 FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. G7 FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. G7 FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 256. G7 FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 257. G7 FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. G7 FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. NATO FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. NATO FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. NATO FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. NATO FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. NATO FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 264. NATO FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 265. NATO FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NATO FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NATO FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 268. NATO FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 269. NATO FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. NATO FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED STATES FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED STATES FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED STATES FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED STATES FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED STATES FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED STATES FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 283. CANADA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. CANADA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. CANADA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 286. CANADA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 287. CANADA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. CANADA FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. MEXICO FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. MEXICO FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. MEXICO FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 296. MEXICO FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 297. MEXICO FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. MEXICO FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 301. MEXICO FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. BRAZIL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. BRAZIL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. BRAZIL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 306. BRAZIL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 307. BRAZIL FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. BRAZIL FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. BRAZIL FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 310. BRAZIL FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 311. BRAZIL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 312. BRAZIL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED KINGDOM FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 316. UNITED KINGDOM FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED KINGDOM FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED KINGDOM FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED KINGDOM FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 323. GERMANY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. GERMANY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. GERMANY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 326. GERMANY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 327. GERMANY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. GERMANY FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. GERMANY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 330. GERMANY FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 331. GERMANY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 332. GERMANY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 333. FRANCE FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. FRANCE FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. FRANCE FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 336. FRANCE FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 337. FRANCE FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. FRANCE FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. FRANCE FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 340. FRANCE FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 341. FRANCE FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 342. FRANCE FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 343. RUSSIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. RUSSIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 345. RUSSIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 346. RUSSIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 347. RUSSIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 348. RUSSIA FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 349. RUSSIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 350. RUSSIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 351. RUSSIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 352. RUSSIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 353. ITALY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 354. ITALY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 355. ITALY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 356. ITALY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 357. ITALY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 358. ITALY FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 359. ITALY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 360. ITALY FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 361. ITALY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 362. ITALY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 363. SPAIN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 364. SPAIN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 365. SPAIN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 366. SPAIN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 367. SPAIN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 368. SPAIN FENTANYL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 369. SPAIN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2024 (USD MILLION)
  • TABLE 370. SPAIN FENTANYL MARKET SIZE, BY MEDICAL USE, 2025-2032 (USD MILLION)
  • TABLE 371. SPAIN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 372. SPAIN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 373. CHINA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 374. CHINA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 375. CHINA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 376. CHINA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 377. CHINA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 378. CHINA FEN